n-methyl-3,4-methylenedioxyamphetamine has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves, E | 1 |
Binienda, Z | 1 |
Carvalho, F | 1 |
Alves, CJ | 1 |
Fernandes, E | 1 |
de Lourdes Bastos, M | 1 |
Tavares, MA | 1 |
Summavielle, T | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.
Topics: Acetylcarnitine; Animals; Body Weight; Brain; Cyclooxygenase 1; DNA, Mitochondrial; Fever; Hallucino | 2009 |